Sort   by:  
 Page size 
UnknownPredictive Modeling Identifies Total Bleeds at 12-Weeks Postswitch to N8-GP Prophylaxis as a Predictor of Treatment Response.
Not available
S-EPMC9251711 | biostudies-literature
UnknownPhase 3 study of recombinant von Willebrand factor in patients with severe von Willebrand disease who are undergoing elective surgery.
Not available
S-EPMC7379610 | biostudies-literature
UnknownLong-term efficacy and safety of subcutaneous concizumab prophylaxis in hemophilia A and hemophilia A/B with inhibitors.
Not available
S-EPMC9198939 | biostudies-literature
UnknownSubcutaneous concizumab prophylaxis in hemophilia A and hemophilia A/B with inhibitors: phase 2 trial results.
Not available
S-EPMC6895373 | biostudies-literature
UnknownTranscriptional diversity during lineage commitment of human blood progenitors.
Not available
S-EPMC4254742 | biostudies-literature
Sort   by:  
 Page size